Exin Therapeutics Lets Claude Operate Brain Surgery

This is a striking demonstration of agentic laboratory control, but the headline is ahead of the evidence: the real milestone is closed-loop experimental decision-making, not proven gene-therapy efficacy.

• –The agent selected from 19 therapies and translated scientific literature into a treatment plan and physical coordinates.
• –Human safeguards remained central: a vet performed the craniotomy, approved irreversible actions, and held an emergency kill switch.
• –A rig-coordinate failure required human code intervention, underscoring the fragility of current lab-agent interfaces.
• –No seizure outcomes, independent validation, full logs, or peer review are available yet.
• –Exin’s broader “in vivo lab-in-the-loop” model could accelerate neurotherapeutic discovery if reproducibility and animal-welfare controls hold up.